// App-Quantinova.ai

: A phase I pilot study of preoperative radiotherapy for prostate cancer: Long-term toxicity and oncologic outcomes.

Researchers

Presenter

  • Noelia Sanmamed

Principal Investigators

  • Rachel Glicksman

  • John Thoms

  • Alexandre Zlotta

  • Antonio Finelli

  • Theodorus Van Der Kwast

  • Joan Sweet

  • Michael Jewett

  • Laurence Klotz

  • Tara Rosewall

  • Neil Eric Fleshner

  • Robert G. Bristow

  • Padraig Warde

  • Alejandro Berlin

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Memorial University of Newfoundland, St. John's, NF, Canada

  • Department of Surgery, Division of Urology, University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • University of Toronto, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Manchester Cancer Research Centre, Manchester, United Kingdom

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT00252447

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved